These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17435860

  • 21. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
    Vilar L, Vilar CF, Lyra R, Freitas MDC.
    Neuroendocrinology; 2019; 109(1):7-19. PubMed ID: 30889571
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.
    Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R, Barros AI, Faria M, Nascimento GC, Lima JG, Nóbrega LH, Cruz TP, Mota A, Ramos A, Violante A, Lamounier Filho A, Gadelha MR, Czepielewski MA, Glezer A, Bronstein MD.
    J Endocrinol Invest; 2008 May; 31(5):436-44. PubMed ID: 18560262
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia.
    Ke X, Wang L, Duan L, Yang H, Yin J, Qiu L, Pan H, Gong F, Zhu H.
    Clin Chim Acta; 2023 Apr 01; 544():117358. PubMed ID: 37086942
    [Abstract] [Full Text] [Related]

  • 25. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
    Amadori P, Dilberis C, Marcolla A, Pinamonti M, Menapace P, Dal Bosco F.
    J Endocrinol Invest; 2003 Feb 01; 26(2):148-56. PubMed ID: 12739743
    [Abstract] [Full Text] [Related]

  • 26. Serum prolactin and macroprolactin levels in diabetic nephropathy.
    Sari F, Sari R, Ozdem S, Sarikaya M, Cetinkaya R.
    Clin Nephrol; 2012 Jul 01; 78(1):33-9. PubMed ID: 22732335
    [Abstract] [Full Text] [Related]

  • 27. A New Method of Using Polyethylene Glycol (PEG) Precipitation of Macroprolactin to Detect Genuine Hyperprolactinemia.
    Chen Y, Wang H, Yang W, Jin W, Yu W, Wang W, Zhang K, Song G.
    J Clin Lab Anal; 2016 Nov 01; 30(6):1169-1174. PubMed ID: 27219457
    [Abstract] [Full Text] [Related]

  • 28. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC, Hsieh CJ.
    Kaohsiung J Med Sci; 2012 Feb 01; 28(2):94-9. PubMed ID: 22313536
    [Abstract] [Full Text] [Related]

  • 29. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M, Guven B, Atmaca H, Acıkgoz S, Mungan G.
    Kaohsiung J Med Sci; 2011 May 01; 27(5):173-6. PubMed ID: 21527183
    [Abstract] [Full Text] [Related]

  • 30. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F, Darendeliler F, Aygün M, Hekim N.
    Turk J Pediatr; 2006 May 01; 48(2):143-7. PubMed ID: 16848115
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.
    Tamer G, Telci A, Mert M, Uzum AK, Aral F, Tanakol R, Yarman S, Boztepe H, Colak N, Alagöl F.
    Endocrine; 2012 Feb 01; 41(1):138-43. PubMed ID: 21959531
    [Abstract] [Full Text] [Related]

  • 32. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C, Bağdatoğlu OT, Muslu N, Köseoğlu A, Dağtekin A, Polat G, Dolgun H, Karataş MA.
    Turk Neurosurg; 2008 Jul 01; 18(3):223-7. PubMed ID: 18814107
    [Abstract] [Full Text] [Related]

  • 33. [Macroprolactinemia identification in patients with hyperprolactinemia].
    Sandoval C, González B, Cheng S, Esquenazi Y, Mercado M.
    Ginecol Obstet Mex; 2007 Aug 01; 75(8):459-64. PubMed ID: 18293675
    [Abstract] [Full Text] [Related]

  • 34. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA, Sthaneshwar P, Hussein Z, Othman N, Chan SP.
    Malays J Pathol; 2013 Jun 01; 35(1):59-63. PubMed ID: 23817395
    [Abstract] [Full Text] [Related]

  • 35. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
    Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK, Sheridan B, Atkinson AB.
    J Clin Endocrinol Metab; 2001 Jun 01; 86(6):2743-6. PubMed ID: 11397880
    [Abstract] [Full Text] [Related]

  • 36. Optimization of a Screening Method for Macroprolactinemia.
    Yang W, Guo Z, Zhou Y, Du J, Liu H, Jia J, Shen Y, Chen Y.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun 15; 1175():122723. PubMed ID: 33989987
    [Abstract] [Full Text] [Related]

  • 37. Macroprolactinemia Detection by Magnetically Assisted Polyethylene Glycol Precipitation: Potential for Automation.
    Smith T, Stern E, Tan E, Vacic A, Fahie-Wilson M.
    J Appl Lab Med; 2020 May 01; 5(3):494-505. PubMed ID: 32445359
    [Abstract] [Full Text] [Related]

  • 38. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ, Vanrell C, Gich I, Urgell E, Calaf J.
    Gynecol Endocrinol; 2017 Feb 01; 33(2):148-151. PubMed ID: 27841032
    [Abstract] [Full Text] [Related]

  • 39. Macroprolactinemia: a mini-review and update on clinical practice.
    Koniares K, Benadiva C, Engmann L, Nulsen J, Grow D.
    F S Rep; 2023 Sep 01; 4(3):245-250. PubMed ID: 37719092
    [Abstract] [Full Text] [Related]

  • 40. Macroprolactinemia and Empty Sella Syndrome.
    Taieb A, Maha KN, El Abed YH, Beizig AM, Chadli MC, Ach K.
    Pan Afr Med J; 2017 Sep 01; 27():278. PubMed ID: 29187947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.